Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc reports results for the quarter ended in March - Earnings Summary

* Mesa Laboratories Inc  MLAB.OQ  reported a quarterly
adjusted
loss of 34 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was
for earnings of 48 cents per share.
    * Revenue rose 55.1% to $58.88 million from a year ago; 
analysts
expected $55.40 million. 
    * Mesa Laboratories Inc's reported EPS for the quarter was a
loss
of 34 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Mesa Laboratories Inc shares had fallen by 14.8% this
quarter and lost 33.8% so far this year.
    * The company reported a quarterly loss of $1.78 million.
    * Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $330.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 31 at 12:55 p.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Mesa Laboratories

See all news